No phaseCompletedHealthspan endpoint
A Clinical Trial for the Evaluation of the Efficacy and Safety of Policosanol in Improving Cognitive Function
A 12-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Policosanol on subjects who have Subjective memory loss
- Sponsor
- Raydel Korea
- Enrollment
- 150 planned
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, NEC
- Ages
- adults, older adults
- Registry
- KCT0012761
Full record on CRiSSource: WHO ICTRP, processed October 5, 2026
Primary outcomes
- ADAS-Cog 11(The Alzheimer's Disease Assessment Scale–Cognitive Subscale, 11-item version) total score
- ADAS-Cog 11(The Alzheimer's Disease Assessment Scale–Cognitive Subscale, 11-item version) memory domain score
- ADAS-Cog 11(The Alzheimer's Disease Assessment Scale–Cognitive Subscale, 11-item version) language/performance domain score
- Visual C.P.T(Visual Continuous Performance Test)
History
Registered
Last registry update
Study completion
Started